Literature DB >> 390559

Ribavirin: an antiviral agent.

R W Sidwell, R K Robins, I W Hillyard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 390559     DOI: 10.1016/0163-7258(79)90058-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  20 in total

Review 1.  Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels.

Authors:  Gillian M Keating; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Clinical presentation and management of suspected ribavirin toxicosis in a dog.

Authors:  Kimberly Bridges; Nicole Beckel; Claire Sharp; Laura Stern
Journal:  Can Vet J       Date:  2016-05       Impact factor: 1.008

4.  Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap.

Authors:  Yifei Yan; Yuri Svitkin; Joseph M Lee; Martin Bisaillon; Jerry Pelletier
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

Review 5.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

6.  The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease.

Authors:  P Glue; S Schenker; S Gupta; R P Clement; D Zambas; M Salfi
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

7.  Ribavirin aerosol for acute bronchiolitis.

Authors:  W Barry; F Cockburn; R Cornall; J F Price; G Sutherland; A Vardag
Journal:  Arch Dis Child       Date:  1986-06       Impact factor: 3.791

8.  Effect of ribavirin on Rous sarcoma virus transformation.

Authors:  F J Jenkins; Y C Chen
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

9.  Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances.

Authors:  D F Smee; R W Sidwell; S M Clark; B B Barnett; R S Spendlove
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

10.  Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses.

Authors:  W M Shannon; G Arnett; L Westbrook; Y F Shealy; C A O'Dell; R W Brockman
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.